Wise R

Top coauthors of Wise R

Andrews J M (160 papers)

Ashby J P (42 papers)

Honeybourne D (38 papers)

Andrews J (17 papers)

Piddock L J (17 papers)

List of Wise R publications

2016

Correa-Martín L, Párraga E, Sánchez-Margallo F M, Latorre R, López-Albors O, et al. 2016. "Mechanical Intestinal Obstruction in a Porcine Model: Effects of Intra-Abdominal Hypertension. A Preliminary Study." PloS one 11 (2) doi:10.1371/journal.pone.0148058

2015

Gordon K, Allorto N, Wise R 2015. "Analysis of referrals and triage patterns in a South African metropolitan adult intensive care service." South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 105 (6) doi:

2011

Ündar A, Palanzo D, Qiu F, Alkan-Bozkaya T, Akcevin A, et al. 2011. "Benefits of pulsatile flow in pediatric cardiopulmonary bypass procedures: from conception to conduction." Perfusion 26 Suppl 1 doi:10.1177/0267659111404468

2010

Diercks D R, Kaufman M J, Irwin R B, Jain A, Robertson L, et al. 2010. "Using a <670> zone axis for convergent beam electron diffraction measurements of lattice strain in strained silicon." Journal of microscopy 239 (2) doi:10.1111/j.1365-2818.2010.03364.x
Han M K, Wise R, Mumford J, Sciurba F, Criner G J, et al. 2010. "Prevalence and clinical correlates of bronchoreversibility in severe emphysema." The European respiratory journal 35 (5) doi:10.1183/09031936.00052509

2007

Andrews J, Honeybourne D, Ashby J, Jevons G, Fraise A, et al. 2007. "Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men." The Journal of antimicrobial chemotherapy 60 (3) doi:10.1093/jac/dkm242
Luo Z W, Potokina E, Druka A, Wise R, Waugh R, Kearsey M J 2007. "SFP genotyping from affymetrix arrays is robust but largely detects cis-acting expression regulators." Genetics 176 (2) doi:10.1534/genetics.106.067843

2006

Wise R, Higginson I, Benger J, Rawlinson N 2006. "Lower limb amputation with CPR in progress: recovery following prolonged cardiac arrest." Emergency medicine journal : EMJ 23 (3) doi:10.1136/emj.2005.030114

2005

Thorp M L, Ditmer D G, Nash M K, Wise R, Jaderholm P L, et al. 2005. "A study of the prevalence of significant increases in serum creatinine following angiotension-converting enzyme inhibitor administration." Journal of human hypertension 19 (5) doi:10.1038/sj.jhh.1001832

2004

Harnett S J, Fraise A P, Andrews J M, Jevons G, Brenwald N P, Wise R 2004. "Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492." The Journal of antimicrobial chemotherapy 53 (5) doi:10.1093/jac/dkh180
Bennett P M, Livesey C T, Nathwani D, Reeves D S, Saunders J R, Wise R 2004. "An assessment of the risks associated with the use of antibiotic resistance genes in genetically modified plants: report of the Working Party of the British Society for Antimicrobial Chemotherapy." The Journal of antimicrobial chemotherapy 53 (3) doi:10.1093/jac/dkh087

2003

Sarani B, Chan T, Wise R, Evans S 2003. "Nissen fundoplication has a vagolytic effect on the lower esophageal sphincter." Surgical endoscopy 17 (8) doi:10.1007/s00464-002-8590-7
Andrews J, Honeybourne D, Jevons G, Boyce M, Wise R, et al. 2003. "Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjects." The Journal of antimicrobial chemotherapy 51 (3) doi:

2002

Wise R 2002. "Nasopharyngeal carriage of Streptococcus pneumoniae: a review of the potential role of pharmacokinetics and pharmacodynamics." The Journal of antimicrobial chemotherapy 50 Suppl S2 doi:
Boswell F J, Andrews J M, Jevons G, Wise R 2002. "Comparison of the in vitro activities of several new fluoroquinolones against respiratory pathogens and their abilities to select fluoroquinolone resistance." The Journal of antimicrobial chemotherapy 50 (4) doi:
Boswell F J, Ashby J P, Andrews J M, Wise R 2002. "Effect of protein binding on the in vitro activity and pharmacodynamics of faropenem." The Journal of antimicrobial chemotherapy 50 (4) doi:
Wise R, Soulsby E J L 2002. "Antibiotic resistance--an evolving problem." The Veterinary record 151 (13) doi:
Wise R, Andrews J M, Ashby J 2002. "In vitro activities of peptide deformylase inhibitors against gram-positive pathogens." Antimicrobial agents and chemotherapy 46 (4) doi:
Ball P, Baquero F, Cars O, File T, Garau J, et al. 2002. "Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence." The Journal of antimicrobial chemotherapy 49 (1) doi:
Weller T M A, Andrews J M, Jevons G, Wise R 2002. "The in vitro activity of BMS-284756, a new des-fluorinated quinolone." The Journal of antimicrobial chemotherapy 49 (1) doi:
Wise R, Gee T, Andrews J M, Dvorchik B, Marshall G 2002. "Pharmacokinetics and inflammatory fluid penetration of intravenous daptomycin in volunteers." Antimicrobial agents and chemotherapy 46 (1) doi:
Wise R, Gee T, Marshall G, Andrews J M 2002. "Single-dose pharmacokinetics and penetration of BMS 284756 into an inflammatory exudate." Antimicrobial agents and chemotherapy 46 (1) doi:

2001

Ploghaus A, Narain C, Beckmann C F, Clare S, Bantick S, et al. 2001. "Exacerbation of pain by anxiety is associated with activity in a hippocampal network." The Journal of neuroscience : the official journal of the Society for Neuroscience 21 (24) doi:
Becerra L, Breiter H C, Wise R, Gonzalez R G, Borsook D 2001. "Reward circuitry activation by noxious thermal stimuli." Neuron 32 (5) doi:
Wise R, Andrews J M, Ashby J P 2001. "Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint." The Journal of antimicrobial chemotherapy 48 (4) doi:
Longe S E, Wise R, Bantick S, Lloyd D, Johansen-Berg H, et al. 2001. "Counter-stimulatory effects on pain perception and processing are significantly altered by attention: an fMRI study." Neuroreport 12 (9) doi:
MacGowan A P, Wise R 2001. "Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests." The Journal of antimicrobial chemotherapy 48 Suppl 1 doi:
Honeybourne D, Banerjee D, Andrews J, Wise R 2001. "Concentrations of gatifloxacin in plasma and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy." The Journal of antimicrobial chemotherapy 48 (1) doi:
Gee T, Ellis R, Marshall G, Andrews J, Ashby J, Wise R 2001. "Pharmacokinetics and tissue penetration of linezolid following multiple oral doses." Antimicrobial agents and chemotherapy 45 (6) doi:10.1128/AAC.45.6.1843-1846.2001
Bühler L, Goepfert C, Kitamura H, Basker M, Gojo S, et al. 2001. "Porcine hematopoietic cell xenotransplantation in nonhuman primates is complicated by thrombotic microangiopathy." Bone marrow transplantation 27 (12) doi:
Khair O A, Andrews J M, Honeybourne D, Jevons G, Vacheron F, Wise R 2001. "Lung concentrations of telithromycin after oral dosing." The Journal of antimicrobial chemotherapy 47 (6) doi:
Gee T, Andrews J M, Ashby J P, Marshall G, Wise R 2001. "Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose." The Journal of antimicrobial chemotherapy 47 (4) doi:
Zhou F, Kurth J, Wei F, Elliott C, Valè G, et al. 2001. "Cell-autonomous expression of barley Mla1 confers race-specific resistance to the powdery mildew fungus via a Rar1-independent signaling pathway." The Plant cell 13 (2) doi:

2000

Andrews J M, Weller T M, Ashby J P, Walker R M, Wise R 2000. "The in vitro activity of ABT773, a new ketolide antimicrobial agent." The Journal of antimicrobial chemotherapy 46 (6) doi:
Andrews J M, Boswell F J, Wise R 2000. "Evaluation of the Oxoid Aura image system for measuring zones of inhibition with the disc diffusion technique." The Journal of antimicrobial chemotherapy 46 (4) doi:
Wise R 2000. "New restraint standards will change your practice." ED management : the monthly update on emergency department management 12 (8) doi:
Harrison J E, Buxton P, Husain M, Wise R 2000. "Short test of semantic and phonological fluency: normal performance, validity and test-retest reliability." The British journal of clinical psychology / the British Psychological Society 39 ( Pt 2) doi:
Andrews J, Ashby J, Jevons G, Marshall T, Lines N, Wise R 2000. "A comparison of antimicrobial resistance rates in Gram-positive pathogens isolated in the UK from October 1996 to January 1997 and October 1997 to January 1998." The Journal of antimicrobial chemotherapy 45 (3) doi:
Wise R, Morrison D 2000. "Beyond the exchange--the future of B2B." Harvard business review 78 (6) doi:
McClanahan P, Edwards M R, Wise R 2000. "Characteristics of Norplant users." Journal of obstetric, gynecologic, and neonatal nursing : JOGNN / NAACOG 29 (3) doi:
Costa S F, Woodcock J, Gill M, Wise R, Barone A A, et al. 2000. "Outer-membrane proteins pattern and detection of beta-lactamases in clinical isolates of imipenem-resistant Acinetobacter baumannii from Brazil." International journal of antimicrobial agents 13 (3) doi:
Wise R 2000. "Clinical efficacy and antimicrobial pharmacodynamics." Hospital medicine (London, England : 1998) 61 (1) doi:
Taylor M L, Noble P W, White B, Wise R, Liu M C, Bochner B S 2000. "Extensive surface phenotyping of alveolar macrophages in interstitial lung disease." Clinical immunology (Orlando, Fla.) 94 (1) doi:10.1006/clim.1999.4803

1999

Andrews J M, Ashby J P, Jevons G M, Wise R 1999. "Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteria." The Journal of antimicrobial chemotherapy 44 (6) doi:
Soman A, Honeybourne D, Andrews J, Jevons G, Wise R 1999. "Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy." The Journal of antimicrobial chemotherapy 44 (6) doi:
Wise R, Andrews J M 1999. "The in-vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinolone." The Journal of antimicrobial chemotherapy 44 (5) doi:
Wise R, Andrews J M, Ashby J P, Marshall J 1999. "A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose." The Journal of antimicrobial chemotherapy 44 (5) doi:
Wise R, Honeybourne D 1999. "Pharmacokinetics and pharmacodynamics of fluoroquinolones in the respiratory tract." The European respiratory journal 14 (1) doi:
Jennings J R, Maricq H R, Canner J, Thompson B, Freedman R R, et al. 1999. "A thermal vascular test for distinguishing between patients with Raynaud's phenomenon and healthy controls. Raynaud's Treatment Study Investigators." Health psychology : official journal of the Division of Health Psychology, American Psychological Association 18 (4) doi:
Atamas S P, Yurovsky V V, Wise R, Wigley F M, Goter Robinson C J, et al. 1999. "Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis." Arthritis and rheumatism 42 (6) doi:10.1002/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L
Wise R, Andrews J M, Marshall G, Hartman G 1999. "Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration." Antimicrobial agents and chemotherapy 43 (6) doi:
Boswell F J, Andrews J M, Wise R, Dalhoff A 1999. "Bactericidal properties of moxifloxacin and post-antibiotic effect." The Journal of antimicrobial chemotherapy 43 Suppl B doi:
Andrews J, Ashby J, Jevons G, Lines N, Wise R 1999. "Antimicrobial resistance in gram-positive pathogens isolated in the UK between October 1996 and January 1997." The Journal of antimicrobial chemotherapy 43 (5) doi:
Gill M J, Brenwald N P, Wise R 1999. "Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae." Antimicrobial agents and chemotherapy 43 (1) doi:
Andrews J M, Ashby J P, Wise R 1999. "Study to assess the reliability of a disc diffusion method for determining the sensitivity of gram-positive pathogens to dalfopristin/quinupristin." The Journal of antimicrobial chemotherapy 43 (1) doi:
Honeybourne D, Andrews J M, Cunningham B, Jevons G, Wise R 1999. "The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy." The Journal of antimicrobial chemotherapy 43 (1) doi:
Wise R 1999. "A review of the mechanisms of action and resistance of antimicrobial agents." Canadian respiratory journal : journal of the Canadian Thoracic Society 6 Suppl A doi:

1998

Boswell F J, Andrews J M, Ashby J P, Fogarty C, Brenwald N P, Wise R 1998. "The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent." The Journal of antimicrobial chemotherapy 42 (6) doi:
Wise R, Andrews J M, Boswell F J, Ashby J P 1998. "The in-vitro activity of linezolid (U-100766) and tentative breakpoints." The Journal of antimicrobial chemotherapy 42 (6) doi:
Weinrich M C, Jacobsen S J, Weinrich S P, Moul J W, Oesterling J E, et al. 1998. "Reference ranges for serum prostate-specific antigen in black and white men without cancer." Urology 52 (6) doi:
Cook P J, Davies P, Wise R, Honeybourne D 1998. "Chlamydia pneumoniae infection and ethnic origin." Ethnicity & health 3 (4) doi:10.1080/13557858.1998.9961866
O'Hara P, Connett J E, Lee W W, Nides M, Murray R, Wise R 1998. "Early and late weight gain following smoking cessation in the Lung Health Study." American journal of epidemiology 148 (9) doi:
Boswell F J, Wise R 1998. "Advances in the macrolides and quinolones." Infectious disease clinics of North America 12 (3) doi:
Gosden P E, Andrews J M, Bowker K E, Holt H A, MacGowan A P, et al. 1998. "Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints." The Journal of antimicrobial chemotherapy 42 (2) doi:
Wise R, Andrews J M 1998. "A comparison of the activity of ciprofloxacin and levofloxacin with other agents against respiratory tract pathogens." Journal of chemotherapy (Florence, Italy) 10 (4) doi:
Brenwald N P, Gill M J, Wise R 1998. "Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae." Antimicrobial agents and chemotherapy 42 (8) doi:
Wise R, Marcangione C, Bauco P 1998. "Blockade of the reward-potentiating effects of nicotine on lateral hypothalamic brain stimulation by chlorisondamine." Synapse (New York, N.Y.) 29 (1) doi:10.1002/(SICI)1098-2396(199805)29:1<72::AID-SYN6>3.0.CO;2-8
Cook P J, Davies P, Tunnicliffe W, Ayres J G, Honeybourne D, Wise R 1998. "Chlamydia pneumoniae and asthma." Thorax 53 (4) doi:
Wise R, Jones S, Das I, Andrews J M 1998. "Pharmacokinetics and inflammatory fluid penetration of clinafloxacin." Antimicrobial agents and chemotherapy 42 (2) doi:
Boswell F J, Andrews J M, Wise R 1998. "Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effect." The Journal of antimicrobial chemotherapy 41 (2) doi:
Cook P J, Lip G Y, Davies P, Beevers D G, Wise R, Honeybourne D 1998. "Chlamydia pneumoniae antibodies in severe essential hypertension." Hypertension 31 (2) doi:
Cook P J, Honeybourne D, Lip G Y, Beevers D G, Wise R, Davies P 1998. "Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project." Stroke; a journal of cerebral circulation 29 (2) doi:
Diculencu D, Andrews J M, Boswell F J, Wise R 1998. "[The postantibiotic effect of azithromycin on respiratory pathogens]." Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i 102 (3-4) doi:

1997

Wise R, Andrews J M 1997. "The activity of grepafloxacin against respiratory pathogens in the UK." The Journal of antimicrobial chemotherapy 40 Suppl A doi:
Andrews J M, Honeybourne D, Jevons G, Brenwald N P, Cunningham B, Wise R 1997. "Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy." The Journal of antimicrobial chemotherapy 40 (4) doi:
Fraise A P, Andrews J, Wise R 1997. "Activity of a new glycopeptide antibiotic (LY333328) against enterococci and other resistant gram-positive organisms." The Journal of antimicrobial chemotherapy 40 (3) doi:
Wise R, Andrews J M, Da Ros L, Child J, Mortiboy D 1997. "A study to determine the pharmacokinetics and inflammatory fluid penetration of two doses of a solid formulation of the hexetil prodrug of a trinem, sanfetrinem (GV 104326)." Antimicrobial agents and chemotherapy 41 (8) doi:
Andrews J M, Honeybourne D, Brenwald N P, Bannerjee D, Iredale M, et al. 1997. "Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy." The Journal of antimicrobial chemotherapy 39 (6) doi:
Boswell F J, Andrews J M, Wise R 1997. "Postantibiotic effect of trovafloxacin on Pseudomonas aeruginosa." The Journal of antimicrobial chemotherapy 39 (6) doi:
Boswell F J, Andrews J M, Wise R 1997. "Pharmacodynamic properties of BAY 12-8039 on gram-positive and gram-negative organisms as demonstrated by studies of time-kill kinetics and postantibiotic effect." Antimicrobial agents and chemotherapy 41 (6) doi:
Black S, Shinefield H, Ray P, Lewis E, Chen R, et al. 1997. "Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project." The Pediatric infectious disease journal 16 (5) doi:
Boswell F J, Sunderland J, Andrews J M, Wise R 1997. "Time-kill kinetics of quinupristin/dalfopristin on Staphylococcus aureus with and without a raised MBC evaluated by two methods." The Journal of antimicrobial chemotherapy 39 Suppl A doi:
Wise R, Brenwald N P, Andrews J M, Boswell F 1997. "The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones." The Journal of antimicrobial chemotherapy 39 (4) doi:
Boswell F J, Andrews J M, Wise R 1997. "Pharmacodynamic properties of faropenem demonstrated by studies of time-kill kinetics and postantibiotic effect." The Journal of antimicrobial chemotherapy 39 (3) doi:
Platel H, Price C, Baron J C, Wise R, Lambert J, et al. 1997. "The structural components of music perception. A functional anatomical study." Brain : a journal of neurology 120 ( Pt 2) doi:
Fraise A P, Mitchell K, O'Brien S J, Oldfield K, Wise R 1997. "Methicillin-resistant Staphylococcus aureus (MRSA) in nursing homes in a major UK city: an anonymized point prevalence survey." Epidemiology and infection 118 (1) doi:
Catchpole C R, Andrews J M, Brenwald N, Wise R 1997. "A reassessment of the in-vitro activity of colistin sulphomethate sodium." The Journal of antimicrobial chemotherapy 39 (2) doi:
Woodcock J M, Andrews J M, Boswell F J, Brenwald N P, Wise R 1997. "In vitro activity of BAY 12-8039, a new fluoroquinolone." Antimicrobial agents and chemotherapy 41 (1) doi:
Woodcock J M, Andrews J M, Brenwald N P, Ashby J P, Wise R 1997. "The in-vitro activity of faropenem, a novel oral penem." The Journal of antimicrobial chemotherapy 39 (1) doi:

1996

Schito G C, Acar J F, Bauernfeind A, Duval J, Finch R G, et al. 1996. "A multinational European survey on the in-vitro activity of rufloxacin and other comparative antibiotics on respiratory and urinary bacterial pathogens." The Journal of antimicrobial chemotherapy 38 (4) doi:
Vandenberghe R, Price C, Wise R, Josephs O, Frackowiak R S 1996. "Functional anatomy of a common semantic system for words and pictures." Nature 383 (6597) doi:10.1038/383254a0
Jónsdóttir M K, Shallice T, Wise R 1996. "Phonological mediation and the graphemic buffer disorder in spelling: cross-language differences?" Cognition 59 (2) doi:
Wise R, Andrews J M, Brenwald N 1996. "In vitro activity of the tricyclic beta-lactam GV104326." Antimicrobial agents and chemotherapy 40 (5) doi:
Wise R, Honeybourne D 1996. "A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses." The Journal of antimicrobial chemotherapy 37 Suppl A doi:
Koppelman S J, van Hoeij M, Vink T, Lankhof H, Schiphorst M E, et al. 1996. "Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C." Blood 87 (6) doi:
Jain S K, Wise R, Bocchini J J 1996. "Vitamin E and vitamin E-quinone levels in red blood cells and plasma of newborn infants and their mothers." Journal of the American College of Nutrition 15 (1) doi:
Cook P J, Andrews J M, Wise R, Honeybourne D 1996. "Distribution of cefdinir, a third generation cephalosporin antibiotic, in serum and pulmonary compartments." The Journal of antimicrobial chemotherapy 37 (2) doi:
Wise R 1996. "Tissue penetration of the fourth generation parenteral cephalosporins." Journal of chemotherapy (Florence, Italy) 8 Suppl 2 doi:
Ling J M, Wise R, Woo T H, Cheng A F 1996. "Investigation of the epidemiology of hospital isolates of Acinetobacter anitratus by two molecular methods." The Journal of hospital infection 32 (1) doi:
Catchpole C, Fraise A, Wise R 1996. "Multidrug-resistant Streptococcus pneumoniae." Microbial drug resistance (Larchmont, N.Y.) 2 (4) doi:
Wise R, Mortiboy D, Child J, Andrews J M 1996. "Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219)." Antimicrobial agents and chemotherapy 40 (1) doi:
Diculencu D, Andrews J M, Boswell F J, Wise R 1996. "[The postantibiotic effect of azithromycin on respiratory pathogens]." Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i 100 (3-4) doi:

1995

Child J, Mortiboy D, Andrews J M, Chow A T, Wise R 1995. "Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid." Antimicrobial agents and chemotherapy 39 (12) doi:
Jain S K, Wise R 1995. "Relationship between elevated lipid peroxides, vitamin E deficiency and hypertension in preeclampsia." Molecular and cellular biochemistry 151 (1) doi:
Lewis D F, Fontenot M T, Brooks G G, Wise R, Perkins M B, Heymann A R 1995. "Latency period after preterm premature rupture of membranes: a comparison of ampicillin with and without sulbactam." Obstetrics and gynecology 86 (3) doi:10.1016/0029-7844(95)00181-P
Child J, Andrews J, Boswell F, Brenwald N, Wise R 1995. "The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents." The Journal of antimicrobial chemotherapy 35 (6) doi:
Fraise A P, Brenwald N, Andrews J M, Wise R 1995. "In-vitro activity of two glycylcyclines against enterococci resistant to other agents." The Journal of antimicrobial chemotherapy 35 (6) doi:
Andrews J M, Wise R, Baldwin D R, Honeybourne D 1995. "Concentrations of ceftibuten in plasma and the respiratory tract following a single 400 mg oral dose." International journal of antimicrobial agents 5 (2) doi:
Child J, Andrews J M, Wise R 1995. "Pharmacokinetics and tissue penetration of the new fluoroquinolone grepafloxacin." Antimicrobial agents and chemotherapy 39 (2) doi:
Cook P J, Andrews J M, Wise R, Honeybourne D, Moudgil H 1995. "Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments." The Journal of antimicrobial chemotherapy 35 (2) doi:
Jain S K, Shah M, Ransonet L, Wise R, Bocchini J A 1995. "Maternal and neonatal plasma transthyretin (prealbumin) concentrations and birth weight of newborn infants." Biology of the neonate 68 (1) doi:
Sunderland J, Brenwald N, Smith E, Andrews J M, Wise R, Honeybourne D 1995. "Enumeration of phagocytosed Staphylococcus aureus inside cells of the mouse macrophage cell line J774 by bioluminescence, fluorescence and viable counting techniques." Journal of bioluminescence and chemiluminescence 10 (5) doi:10.1002/bio.1170100506

1994

Démonet J F, Price C, Wise R, Frackowiak R S 1994. "Differential activation of right and left posterior sylvian regions by semantic and phonological tasks: a positron-emission tomography study in normal human subjects." Neuroscience letters 182 (1) doi:
Wise R, Andrews J M, Thornber D 1994. "The in-vitro activity of FK-037, a new broad spectrum injectable cephalosporin." The Journal of antimicrobial chemotherapy 34 (5) doi:
Cook P J, Andrews J M, Woodcock J, Wise R, Honeybourne D 1994. "Concentration of amoxycillin and clavulanate in lung compartments in adults without pulmonary infection." Thorax 49 (11) doi:
Wise R 1994. "Comparative microbiological activity and pharmacokinetics of cefprozil." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 13 (10) doi:
Wise R, Andrews J M, O'Neill P, Jolley A, Fowler C, Rogge M C 1994. "Pharmacokinetics and distribution in tissue of FK-037, a new parenteral cephalosporin." Antimicrobial agents and chemotherapy 38 (10) doi:
Démonet J F, Price C, Wise R, Frackowiak R S 1994. "A PET study of cognitive strategies in normal subjects during language tasks. Influence of phonetic ambiguity and sequence processing on phoneme monitoring." Brain : a journal of neurology 117 ( Pt 4) doi:
Cheng A F, Li M S, Chan C Y, Chan C H, Lyon D, et al. 1994. "Evaluation of three culture media and their combinations for the isolation of Mycobacterium tuberculosis from pleural aspirates of patients with tuberculous pleurisy." The Journal of tropical medicine and hygiene 97 (4) doi:
Honeybourne D, Greaves I, Baldwin D R, Andrews J M, Harris M, Wise R 1994. "The concentration of sparfloxacin in lung tissues after single and multiple oral doses." International journal of antimicrobial agents 4 (3) doi:
Honeybourne D, Kees F, Andrews J M, Baldwin D, Wise R 1994. "The levels of clarithromycin and its 14-hydroxy metabolite in the lung." The European respiratory journal 7 (7) doi:
Woodcock J M, Andrews J M, Honeybourne D, Wise R 1994. "Determination of OPC-17116, a new fluoroquinolone, in human alveolar macrophages and other biological matrices by high performance liquid chromatography (HPLC)." FEMS microbiology letters 119 (3) doi:
Wise R, Andrews J M 1994. "In vitro activities of two glycylcyclines." Antimicrobial agents and chemotherapy 38 (5) doi:
Hextall A, Radley S, Andrews J M, Boyd E J, Dent J C, et al. 1994. "Mucosal concentration and excretion of clindamycin by the human stomach." The Journal of antimicrobial chemotherapy 33 (3) doi:
Jain S K, McCoy B, Wise R 1994. "Vitamin E and the hypercoagulability of neonatal blood." Clinica chimica acta; international journal of clinical chemistry 225 (2) doi:
Catchpole C, Andrews J M, Woodcock J, Wise R 1994. "The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po." The Journal of antimicrobial chemotherapy 33 (1) doi:

1993

Lees A S, Andrews J M, Wise R 1993. "The pharmacokinetics, tissue penetration and in-vitro activity of loracarbef, a beta-lactam antibiotic of the carbacephem class." The Journal of antimicrobial chemotherapy 32 (6) doi:
Wise R, Andrews J, Imbimbo B P, Greaves I, Honeybourne D 1993. "The penetration of rufloxacin into sites of potential infection in the respiratory tract." The Journal of antimicrobial chemotherapy 32 (6) doi:
Baldwin D R, Wise R, Andrews J M, Gill M, Honeybourne D 1993. "Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration." Respiratory medicine 87 (8) doi:
Triger D R, Granai F, Woodcock J, Wise R, Imbimbo B P 1993. "Multiple-dose pharmacokinetics of rufloxacin in patients with cirrhosis." Hepatology (Baltimore, Md.) 18 (4) doi:
Penner G A, Bush A, Wise R, Kim W, Domier L, et al. 1993. "Reproducibility of random amplified polymorphic DNA (RAPD) analysis among laboratories." PCR methods and applications 2 (4) doi:
Cheng A F, Ling T K, Lam A W, Fung K S, Wise R 1993. "The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents." The Journal of antimicrobial chemotherapy 31 (5) doi:
Perry G, Mant T G, Morrison P J, Sacks S, Woodcook J, et al. 1993. "Pharmacokinetics of rufloxacin in patients with impaired renal function." Antimicrobial agents and chemotherapy 37 (4) doi:
Wise R, Andrews J M, Brenwald N 1993. "The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone." The Journal of antimicrobial chemotherapy 31 (4) doi:
Matthews R S, Pandit P G, Bonigal S D, Wise R, Radcliffe K W 1993. "Evaluation of an enzyme-linked immunoassay and confirmatory test for the detection of Chlamydia trachomatis in male urine samples." Genitourinary medicine 69 (1) doi:
Wise R 1993. "The efficacy and safety of piperacillin/tazobactam in the therapy of bacteraemia." The Journal of antimicrobial chemotherapy 31 Suppl A doi:
Wise R, Andrews J M, Brenwald N 1993. "The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone." The Journal of antimicrobial chemotherapy 31 (1) doi:

1992

Démonet J F, Chollet F, Ramsay S, Cardebat D, Nespoulous J L, et al. 1992. "The anatomy of phonological and semantic processing in normal subjects." Brain : a journal of neurology 115 ( Pt 6) doi:
Howard D, Patterson K, Wise R, Brown W D, Friston K, et al. 1992. "The cortical localization of the lexicons. Positron emission tomography evidence." Brain : a journal of neurology 115 ( Pt 6) doi:
Price C, Wise R, Ramsay S, Friston K, Howard D, et al. 1992. "Regional response differences within the human auditory cortex when listening to words." Neuroscience letters 146 (2) doi:
Johnson J H, Cooper M A, Andrews J M, Wise R 1992. "Pharmacokinetics and inflammatory fluid penetration of sparfloxacin." Antimicrobial agents and chemotherapy 36 (11) doi:
Riess G, Andrews J, Thornber D, Wise R 1992. "In vitro activity of RU 29246, the active compound of the cephalosporin prodrug ester HR 916." Antimicrobial agents and chemotherapy 36 (11) doi:
Roscoe D L, Zemcov S J, Thornber D, Wise R, Clarke A M 1992. "Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species." Antimicrobial agents and chemotherapy 36 (10) doi:
Baldwin D R, Andrews J M, Wise R, Honeybourne D 1992. "Bronchoalveolar distribution of cefuroxime axetil and in-vitro efficacy of observed concentrations against respiratory pathogens." The Journal of antimicrobial chemotherapy 30 (3) doi:
Catchpole C R, Wise R, Thornber D, Andrews J M 1992. "In vitro activity of L-627, a new carbapenem." Antimicrobial agents and chemotherapy 36 (9) doi:
Baldwin D R, Wise R, Andrews J M, Honeybourne D 1992. "Quantitative morphology and water distribution of bronchial biopsy samples." Thorax 47 (7) doi:
Baldwin D R, Wise R, Andrews J M, Honeybourne D 1992. "Concentrations of cefpodoxime in serum and bronchial mucosal biopsies." The Journal of antimicrobial chemotherapy 30 (1) doi:
Wise R, Andrews J M, Matthews R, Wolstenholme M 1992. "The in-vitro activity of two new quinolones: rufloxacin and MF 961." The Journal of antimicrobial chemotherapy 29 (6) doi:
Cooper M A, Andrews J M, Wise R 1992. "In-vitro activity of tosufloxacin, a new quinolone antibacterial agent." The Journal of antimicrobial chemotherapy 29 (6) doi:
Koscielniak-Nielsen Z J, Law-Min J C, Donati F, Bevan D R, Clement P, Wise R 1992. "Dose-response relations of doxacurium and its reversal with neostigmine in young adults and healthy elderly patients." Anesthesia and analgesia 74 (6) doi:
Wise R, O'Sullivan N, Johnson J, Andrews J M 1992. "Pharmacokinetics and tissue penetration of ampicillin and brobactam following oral administration of 2085P." Antimicrobial agents and chemotherapy 36 (5) doi:
Cooper M A, Andrews J M, Wise R 1992. "In-vitro activity of PD 131628, a new quinolone antimicrobial agent." The Journal of antimicrobial chemotherapy 29 (5) doi:
Baldwin D R, Wise R, Andrews J M, Ashby J P, Honeybourne D 1992. "The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa." The European respiratory journal 5 (4) doi:
Tashkin D P, Altose M D, Bleecker E R, Connett J E, Kanner R E, et al. 1992. "The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group." The American review of respiratory disease 145 (2 Pt 1) doi:
Singh K B, Wise R, Otterson W N, Dunnihoo D R 1992. "Asymptomatic heterotopic ovarian pregnancy." Southern medical journal 85 (1) doi:

1991

Wise R 1991. "Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues." The American journal of medicine 91 (6A) doi:
Wise R, Johnson J, O'Sullivan N, Andrews J M, Imbimbo B P 1991. "Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent." The Journal of antimicrobial chemotherapy 28 (6) doi:
Wise R, Baldwin D R, Andrews J M, Honeybourne D 1991. "Comparative pharmacokinetic disposition of fluoroquinolones in the lung." The Journal of antimicrobial chemotherapy 28 Suppl C doi:
Tashkin D P, Rand C, Nides M, Simmons M, Wise R, et al. 1991. "A nebulizer chronolog to monitor compliance with inhaler use." The American journal of medicine 91 (4A) doi:
Cooper M A, Andrews J M, Wise R 1991. "Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions." The Journal of antimicrobial chemotherapy 28 (3) doi:
Cooper M A, Baldwin D, Matthews R S, Andrews J M, Wise R 1991. "In-vitro susceptibility of Chlamydia pneumoniae (TWAR) to seven antibiotics." The Journal of antimicrobial chemotherapy 28 (3) doi:
Baldwin D R, Wise R, Andrews J M, Honeybourne D 1991. "Microlavage: a technique for determining the volume of epithelial lining fluid." Thorax 46 (9) doi:
Cooper M A, Andrews J M, Baldwin D R, Thornber D, Wise R 1991. "In-vitro activity and beta-lactamase stability of SR 44337, a new long acting cephalosporin." The Journal of antimicrobial chemotherapy 28 (2) doi:
Wise R, Andrews J M, Thornber D 1991. "The in-vitro activity of cefdinir (FK482), a new oral cephalosporin." The Journal of antimicrobial chemotherapy 28 (2) doi:
Wise R, Chollet F, Hadar U, Friston K, Hoffner E, Frackowiak R 1991. "Distribution of cortical neural networks involved in word comprehension and word retrieval." Brain : a journal of neurology 114 ( Pt 4) doi:
Baldwin D R, Maxwell S R, Honeybourne D, Andrews J M, Ashby J P, Wise R 1991. "The penetration of cefpirome into the potential sites of pulmonary infection." The Journal of antimicrobial chemotherapy 28 (1) doi:
Wise R, Logan M, Cooper M, Andrews J M 1991. "Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin." Antimicrobial agents and chemotherapy 35 (6) doi:
Reeves D S, Holt H A, Phillips I, King A, Miles R S, et al. 1991. "Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centres." The Journal of antimicrobial chemotherapy 27 (4) doi:
Wise R, Andrews J M, Ashby J P, Thornber D 1991. "In vitro activity of a catechol-substituted cephalosporin, GR69153." Antimicrobial agents and chemotherapy 35 (2) doi:
Logan M N, Ashby J P, Andrews J M, Wise R 1991. "The in-vitro and disc susceptibility testing of clarithromycin and its 14-hydroxy metabolite." The Journal of antimicrobial chemotherapy 27 (2) doi:
Wise R, Hadar U, Howard D, Patterson K 1991. "Language activation studies with positron emission tomography." Ciba Foundation symposium 163 doi:
Wise R, Andrews J M, Ashby J P, Thornber D 1991. "Ceftibuten: a new orally absorbed cephalosporin. In vitro activity against strains from the United Kingdom." Diagnostic microbiology and infectious disease 14 (1) doi:

1990

Wise R 1990. "The pharmacokinetics of the oral cephalosporins--a review." The Journal of antimicrobial chemotherapy 26 Suppl E doi:
Piddock L J, Traynor E A, Wise R 1990. "A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae." The Journal of antimicrobial chemotherapy 26 (6) doi:
Wise R, Andrews J M, Ashby J P 1990. "In-vitro activity of cefodizime against respiratory pathogens." The Journal of antimicrobial chemotherapy 26 Suppl C doi:
Cooper M A, Andrews J M, Ashby J P, Matthews R S, Wise R 1990. "In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent." The Journal of antimicrobial chemotherapy 26 (5) doi:
Cooper M A, Nye K, Andrews J M, Wise R 1990. "The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin." The Journal of antimicrobial chemotherapy 26 (4) doi:
Nye K, Chadha D K, Hodgkin P, Bradley C, Hancox J, Wise R 1990. "Mycobacterium chelonei isolation from broncho-alveolar lavage fluid and its practical implications." The Journal of hospital infection 16 (3) doi:
Baldwin D R, Wise R, Andrews J M, Ashby J P, Honeybourne D 1990. "Azithromycin concentrations at the sites of pulmonary infection." The European respiratory journal 3 (8) doi:
Wise R, Logan M, Cooper M, Ashby J P, Andrews J M 1990. "Meropenem pharmacokinetics and penetration into an inflammatory exudate." Antimicrobial agents and chemotherapy 34 (8) doi:
Wise R, Andrews J M, Ashby J P, Thornber D 1990. "Ceftibuten--in-vitro activity against respiratory pathogens, beta-lactamase stability and mechanism of action." The Journal of antimicrobial chemotherapy 26 (2) doi:
Cooper M A, Jin Y F, Ashby J P, Andrews J M, Wise R 1990. "In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin." The Journal of antimicrobial chemotherapy 26 (2) doi:
Baldwin D R, Honeybourne D, Andrews J M, Ashby J P, Wise R 1990. "Concentrations of oral lomefloxacin in serum and bronchial mucosa." Antimicrobial agents and chemotherapy 34 (6) doi:
Wise R, Nye K, O'Neill P, Wostenholme M, Andrews J M 1990. "Pharmacokinetics and tissue penetration of ceftibuten." Antimicrobial agents and chemotherapy 34 (6) doi:
Baldwin D R, Wilkinson L, Andrews J M, Ashby J P, Wise R, Honeybourne D 1990. "Concentrations of temafloxacin in serum and bronchial mucosa." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 9 (6) doi:
Chadha D, Wise R, Baldwin D R, Andrews J M, Ashby J P, Honeybourne D 1990. "Cefepime concentrations in bronchial mucosa and serum following a single 2 gram intravenous dose." The Journal of antimicrobial chemotherapy 25 (6) doi:
Kumararatne D S, Pithie A S, Drysdale P, Gaston J S, Kiessling R, et al. 1990. "Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC-restricted polyclonal T cell lines in healthy donors or patients with tuberculosis." Clinical and experimental immunology 80 (3) doi:
Piddock L J, Hall M C, Wise R 1990. "Mechanism of action of lomefloxacin." Antimicrobial agents and chemotherapy 34 (6) doi:
Baldwin D R, Andrews J M, Ashby J P, Wise R, Honeybourne D 1990. "Concentrations of cefixime in bronchial mucosa and sputum after three oral multiple dose regimens." Thorax 45 (5) doi:
Nye K, O'Neill P, Andrews J M, Wise R 1990. "Pharmacokinetics and tissue penetration of cefprozil." The Journal of antimicrobial chemotherapy 25 (5) doi:
Wise R, Andrews J M, Ashby J P, Thornber D 1990. "In vitro activity of Bay v 3522, a new cephalosporin, compared with activities of other agents." Antimicrobial agents and chemotherapy 34 (5) doi:
Wise R, Andrews J M, Ashby J P, Thornber D 1990. "The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins." The Journal of antimicrobial chemotherapy 25 (4) doi:
Burkitt D S, Donovan I A, Wise R, Lowe P 1990. "A comparison between imipenem and metronidazole prophylaxis against sepsis following appendicectomy." The Journal of hospital infection 15 (3) doi:
Fessler H E, Brower R G, Wise R, Permutt S 1990. "Positive pleural pressure decreases coronary perfusion." The American journal of physiology 258 (3 Pt 2) doi:
Diver J M, Piddock L J, Wise R 1990. "The accumulation of five quinolone antibacterial agents by Escherichia coli." The Journal of antimicrobial chemotherapy 25 (3) doi:
O'Neill P, Nye K, Douce G, Andrews J, Wise R 1990. "Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteers." Antimicrobial agents and chemotherapy 34 (2) doi:
Jawad A J, Manuel G, Matthews R, Wise R, Clay J C 1990. "Evaluation of a genus-specific monoclonal antibody in an amplified enzyme-linked immunoassay in the detection of Chlamydia in urine samples from men." Sexually transmitted diseases 17 (2) doi:

1989

Walters R N, Piddock L J, Wise R 1989. "The effect of mutations in the SOS response on the kinetics of quinolone killing." The Journal of antimicrobial chemotherapy 24 (6) doi:
Wise R, Ashby J P, Andrews J M 1989. "The antibacterial activity of meropenem in combination with gentamicin or vancomycin." The Journal of antimicrobial chemotherapy 24 Suppl A doi:
Nye K, Shi Y G, Andrews J M, Ashby J P, Wise R 1989. "The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin." The Journal of antimicrobial chemotherapy 24 (3) doi:
Griggs D J, Wise R 1989. "A simple isocratic high-pressure liquid chromatographic assay of quinolones in serum." The Journal of antimicrobial chemotherapy 24 (3) doi:
Nye K J, Shi Y G, Andrews J M, Wise R 1989. "Pharmacokinetics and tissue penetration of cefepime." The Journal of antimicrobial chemotherapy 24 (1) doi:
Kavi J, Ashby J P, Wise R, Donovan I A 1989. "Intraperitoneal penetration of cefpirome." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 8 (6) doi:
Andrews J M, Wise R 1989. "The in vitro activity of tigemonam: a comparison with other antimicrobial agents." Journal of chemotherapy (Florence, Italy) 1 Suppl 2 doi:
Andrews J M, Wise R 1989. "The In Vitro Activity of Tigemonam: a Comparison with Other Antimicrobial Agents." Journal of chemotherapy (Florence, Italy) 1 (sup2) doi:10.1080/1120009X.1989.11738941
Wise R, Ballard R C 1989. "Review of the in-vitro evaluation of FCE 22101." The Journal of antimicrobial chemotherapy 23 Suppl C doi:
MacGowan A P, Greig M A, Andrews J M, Reeves D S, Wise R 1989. "Pharmacokinetics and tolerance of a new film-coated tablet of sodium fusidate administered as a single oral dose to healthy volunteers." The Journal of antimicrobial chemotherapy 23 (3) doi:
Piddock L J, Traynor E A, Wise R 1989. "Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteins." The Journal of antimicrobial chemotherapy 23 Suppl C doi:
Kavi J, Stone J, Andrews J M, Ashby J P, Wise R 1989. "Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses." European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 8 (2) doi:
Stone J W, Linong G, Andrews J M, Wise R 1989. "Cefixime, in-vitro activity, pharmacokinetics and tissue penetration." The Journal of antimicrobial chemotherapy 23 (2) doi:
Griggs D J, Piddock L J, Wise R 1989. "The killing action of fleroxacin upon Bacteroides fragilis." The Journal of antimicrobial chemotherapy 23 (1) doi:

1988

Kavi J, Andrews J M, Ashby J P, Hillman G, Wise R 1988. "Pharmacokinetics and tissue penetration of cefpirome, a new cephalosporin." The Journal of antimicrobial chemotherapy 22 (6) doi:
Griggs D J, Wise R, Kirkpatrick B, Ashby J P 1988. "The metabolism and pharmacokinetics of fleroxacin in healthy subjects." The Journal of antimicrobial chemotherapy 22 Suppl D doi:
Stone J W, Andrews J M, Ashby J P, Griggs D, Wise R 1988. "Pharmacokinetics and tissue penetration of orally administered lomefloxacin." Antimicrobial agents and chemotherapy 32 (10) doi:
Piddock L J, Wise R 1988. "The selection and frequency of streptococci with decreased susceptibility to ofloxacin compared with other quinolones." The Journal of antimicrobial chemotherapy 22 Suppl C doi:
Wise R, Lockley M R 1988. "The pharmacokinetics of ofloxacin and a review of its tissue penetration." The Journal of antimicrobial chemotherapy 22 Suppl C doi:
Honeybourne D, Andrews J M, Ashby J P, Lodwick R, Wise R 1988. "Evaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosa." Thorax 43 (9) doi:
Wise R, Honeybourne D, Andrews J M, Ashby J P 1988. "The penetration of fleroxacin into bronchial mucosa." The Journal of antimicrobial chemotherapy 22 (2) doi:
Wise R, Ashby J P, Andrews J M 1988. "In vitro activity of PD 127,391, an enhanced-spectrum quinolone." Antimicrobial agents and chemotherapy 32 (8) doi:
Kavi J, Webberley J M, Andrews J M, Wise R 1988. "A comparison of the pharmacokinetics and tissue penetration of spiramycin and erythromycin." The Journal of antimicrobial chemotherapy 22 Suppl B doi:
Wise R, Andrews J M, Ashby J P, Matthews R S 1988. "In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents." Antimicrobial agents and chemotherapy 32 (5) doi:
Webberley J M, Wise R, Andrews J M, Ashby J P, Wallbridge D 1988. "The pharmacokinetics and tissue penetration of FCE 22101 following intravenous and oral administration." The Journal of antimicrobial chemotherapy 21 (4) doi:
Wise R, Webberley J M, Andrews J M, Ashby J P 1988. "The pharmacokinetics and tissue penetration of intravenously administered CGP 31608." The Journal of antimicrobial chemotherapy 21 (1) doi:
Wise R, Griggs D, Andrews J M 1988. "Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule." Reviews of infectious diseases 10 Suppl 1 doi:

1987

Andrews J M, Ashby J P, Wise R 1987. "Factors affecting the in-vitro activity of roxithromycin." The Journal of antimicrobial chemotherapy 20 Suppl B doi:
Nelson W L, Wise R, Kuritsky J N 1987. "Cardiorespiratory arrests temporally associated with injection of intravenous ampicillin in infants: investigation of a suspected cluster." Pediatrics 80 (5) doi:
Webberley J M, Matthews R S, Andrews J M, Wise R 1987. "Commercially available fluorescein-conjugated monoclonal antibody for determining the in vitro activity of antimicrobial agents against Chlamydia trachomatis." European journal of clinical microbiology 6 (5) doi:
Webberley J M, Andrews J M, Ashby J P, McLeod A, Wise R 1987. "Pharmacokinetics and tissue penetration of orally administered pefloxacin." European journal of clinical microbiology 6 (5) doi:
Ashby J, Kirkpatrick B, Piddock L J, Wise R 1987. "The effect of imipenem on strains of Enterobacteriaceae expressing Richmond & Sykes class I beta-lactamases." The Journal of antimicrobial chemotherapy 20 (1) doi:
Wise R, Kirkpatrick B, Ashby J, Andrews J M 1987. "Pharmacokinetics and tissue penetration of roxithromycin after multiple dosing." Antimicrobial agents and chemotherapy 31 (7) doi:
Wise R, Donovan I A 1987. "Tissue penetration and metabolism of ciprofloxacin." The American journal of medicine 82 (4A) doi:
Wise R, Baker S L, Misra M, Griggs D 1987. "The pharmacokinetics of enoxacin in elderly patients." The Journal of antimicrobial chemotherapy 19 (3) doi:
Manek N, Wise R, Donovan I A 1987. "Intraperitoneal penetration of ticarcillin/clavulanic acid (Timentin)." The Journal of antimicrobial chemotherapy 19 (3) doi:
Gould I M, Dent J, Wise R 1987. "In-vitro bacterial killing kinetics of ticarcillin/clavulanic acid." The Journal of antimicrobial chemotherapy 19 (3) doi:
Piddock L J, Wise R 1987. "Cefoxitin resistance in Bacteroides species: evidence indicating two mechanisms causing decreased susceptibility." The Journal of antimicrobial chemotherapy 19 (2) doi:
Wise R, Kirkpatrick B, Ashby J, Griggs D J 1987. "Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone." Antimicrobial agents and chemotherapy 31 (2) doi:
Wise R, Andrews J M, Piddock L J 1987. "In vitro activity of CGP 31608, a new penem." Antimicrobial agents and chemotherapy 31 (2) doi:

1986

Wise R, Donovan I A, Lockley M R, Drumm J, Andrews J M 1986. "The pharmacokinetics and tissue penetration of imipenem." The Journal of antimicrobial chemotherapy 18 Suppl E doi:
Wise R, Lister D, McNulty C A, Griggs D, Andrews J M 1986. "The comparative pharmacokinetics of five quinolones." The Journal of antimicrobial chemotherapy 18 Suppl D doi:
Diver J M, Wise R 1986. "Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin." The Journal of antimicrobial chemotherapy 18 Suppl D doi:
McNulty C A, Gearty J C, Crump B, Davis M, Donovan I A, et al. 1986. "Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate." British medical journal (Clinical research ed.) 293 (6548) doi:
Piddock L J, Diver J M, Wise R 1986. "Cross-resistance of nalidixic acid resistant Enterobacteriaceae to new quinolones and other antimicrobials." European journal of clinical microbiology 5 (4) doi:
Manek N, Andrews J M, Wise R 1986. "In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents." Antimicrobial agents and chemotherapy 30 (2) doi:
Wise R, Andrews J M, Piddock L J 1986. "In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites." Antimicrobial agents and chemotherapy 29 (6) doi:
Piddock L J, Andrews J M, Diver J M, Wise R 1986. "In vitro studies of S-25930 and S-25932, two new 4-quinolones." European journal of clinical microbiology 5 (3) doi:
Piddock L J, Wise R 1986. "Properties of the penicillin-binding proteins of four species of the genus Bacteroides." Antimicrobial agents and chemotherapy 29 (5) doi:
Wise R, Donovan I A, McNulty C A, Waldron R, Andrews J M 1986. "Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration." The Journal of hospital infection 7 Suppl A doi:
Wise R, Lister D, McNulty C A, Griggs D, Andrews J M 1986. "The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin." Infection 14 Suppl 3 doi:
Grimer R J, Karpinski M R, Andrews J M, Wise R 1986. "Penetration of amoxycillin and clavulanic acid into bone." Chemotherapy 32 (3) doi:
Wise R 1986. "Methods for evaluating the penetration of beta-lactam antibiotics into tissues." Reviews of infectious diseases 8 Suppl 3 doi:
Wise R 1986. "The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy." Clinical pharmacokinetics 11 (6) doi:
Wise R, Gibbs J, Frackowiak R, Marshall J, Jones T 1986. "No evidence for transhemispheric diaschisis after human cerebral infarction." Stroke; a journal of cerebral circulation 17 (5) doi:

1985

McNulty C A, Garden G M, Wise R, Andrews J M 1985. "The pharmacokinetics and tissue penetration of teicoplanin." The Journal of antimicrobial chemotherapy 16 (6) doi:
McNulty C A, Dent J, Wise R 1985. "Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents." Antimicrobial agents and chemotherapy 28 (6) doi:
Drumm J, Donovan I A, Wise R 1985. "A comparison of cefotetan and cephazolin for prophylaxis against wound infection after elective cholecystectomy." The Journal of hospital infection 6 (3) doi:
McNulty C A, Garden G M, Ashby J, Wise R 1985. "Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam." Antimicrobial agents and chemotherapy 28 (3) doi:
Drumm J, Donovan I A, Wise R, Lowe P 1985. "Metronidazole and Augmentin in the prevention of sepsis after appendicectomy." The British journal of surgery 72 (7) doi:
Piddock L J, Wise R 1985. "The mode of action of Sch 34343: affinity for the penicillin binding proteins of Escherichia coli K-12 and Bacteroides fragilis." The Journal of antimicrobial chemotherapy 15 Suppl C doi:
Wise R, Andrews J M, Cross C, Piddock L J 1985. "The antimicrobial activity of cefpirome, a new cephalosporin." The Journal of antimicrobial chemotherapy 15 (4) doi:
Low D C, Bissenden J G, Wise R 1985. "Ceftazidime in neonatal infections." Archives of disease in childhood 60 (4) doi:
Wise R, Andrews J M, Piddock L J 1985. "The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agents." The Journal of antimicrobial chemotherapy 15 (2) doi:
Emmerson A M, Lamport P A, Reeves D S, Bywater M J, Holt H A, et al. 1985. "The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics." Current medical research and opinion 9 (7) doi:10.1185/03007998509109622
Lockley M R, Brown R M, Wise R 1985. "Pharmacokinetics and tissue penetration of temocillin." Drugs 29 Suppl 5 doi:
Wise R, Wright N 1985. "The pharmacokinetics of cefotaxime and ceftriaxone in renal and hepatic dysfunction." Infection 13 Suppl 1 doi:

1984

Wise R, Cross C, Andrews J M 1984. "In vitro activity of CGP 31523A, a broad-spectrum cephalosporin, in comparison with those of other agents." Antimicrobial agents and chemotherapy 26 (6) doi:
Lockley M R, Wise R, Dent J 1984. "The pharmacokinetics and tissue penetration of ofloxacin." The Journal of antimicrobial chemotherapy 14 (6) doi:
Andrews J M, Wise R 1984. "A comparison of the homogeneous enzyme immunoassay and polarization fluoroimmunoassay of gentamicin." The Journal of antimicrobial chemotherapy 14 (5) doi:
Wise R, Lockley R, Webberly M, Adhami Z N 1984. "The pharmacokinetics and tissue penetration of enoxacin and norfloxacin." The Journal of antimicrobial chemotherapy 14 Suppl C doi:
Wise R, Lockley R M, Webberly M, Dent J 1984. "Pharmacokinetics of intravenously administered ciprofloxacin." Antimicrobial agents and chemotherapy 26 (2) doi:
Wise R, Lockley R, Dent J, Webberly M 1984. "Pharmacokinetics and tissue penetration of enoxacin." Antimicrobial agents and chemotherapy 26 (1) doi:
Wise R, Bennett S A, Dent J 1984. "The pharmacokinetics of orally absorbed cefuroxime compared with amoxycillin/clavulanic acid." The Journal of antimicrobial chemotherapy 13 (6) doi:
Wise R 1984. "Norfloxacin--a review of pharmacology and tissue penetration." The Journal of antimicrobial chemotherapy 13 Suppl B doi:
Wise R, Andrews J M 1984. "In vitro activity of fludalanine combined with pentizidone compared with those of other agents." Antimicrobial agents and chemotherapy 25 (5) doi:
Wise R, Andrews J M, Danks G 1984. "In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents." The Journal of antimicrobial chemotherapy 13 (3) doi:
Adhami Z N, Wise R, Weston D, Crump B 1984. "The pharmacokinetics and tissue penetration of norfloxacin." The Journal of antimicrobial chemotherapy 13 (1) doi:

1983

Wise R, Andrews J M, Danks G 1983. "Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics." Antimicrobial agents and chemotherapy 24 (6) doi:
Crump B, Wise R, Dent J 1983. "Pharmacokinetics and tissue penetration of ciprofloxacin." Antimicrobial agents and chemotherapy 24 (5) doi:
Wise R, Andrews J M 1983. "A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime." European journal of clinical microbiology 2 (5) doi:
Dyas A, Wise R, Pijck J, Hallynck T, Acar J, et al. 1983. "Reproducibility study of the pharmacokinetics of amikacin, gentamicin and tobramycin; a three-way crossover study." The Journal of antimicrobial chemotherapy 12 (4) doi:
Ambrose N S, Donovan I A, Wise R, Lowe P 1983. "Metronidazole and ticarcillin in the prevention of sepsis after appendicectomy." American journal of surgery 146 (3) doi:
Wise R, Donovan I A, Drumm J, Dent J, Bennett S A 1983. "Intraperitoneal penetration of cefotetan." Antimicrobial agents and chemotherapy 24 (2) doi:
Wise R, Donovan I A, Andrews J M, Drumm J, Bennett S 1983. "Penetration of sulbactam and ampicillin into peritoneal fluid." Antimicrobial agents and chemotherapy 24 (2) doi:
Wise R, Donovan I A, Drumm J, Dyas A, Cross C 1983. "The intraperitoneal penetration of temocillin." The Journal of antimicrobial chemotherapy 12 (1) doi:
Wright N, Wise R 1983. "The elimination of sulbactam alone and combined with ampicillin in patients with renal dysfunction." The Journal of antimicrobial chemotherapy 11 (6) doi:
Thompson W E, Wise R 1983. "Comparison of counterimmunoelectrophoresis and latex particle agglutination in the detection of Streptococcus pneumoniae in blood cultures." The Journal of hospital infection 4 (2) doi:
Bennett S, Wise R, Weston D, Dent J 1983. "Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid." Antimicrobial agents and chemotherapy 23 (6) doi:
Wright N, Wise R, Price J D 1983. "Temocillin elimination in patients with varying degrees of renal failure." The Journal of antimicrobial chemotherapy 11 (5) doi:
Wise R, Andrews J M, Edwards L J 1983. "In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents." Antimicrobial agents and chemotherapy 23 (4) doi:
Sheppard G, Gruzelier J, Manchanda R, Hirsch S R, Wise R, et al. 1983. "15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients." Lancet 2 (8365-66) doi:
Wise R, Donovan I A, Drumm J, Andrews J M, Stephenson P 1983. "The penetration of amoxycillin/clavulanic acid into peritoneal fluid." The Journal of antimicrobial chemotherapy 11 (1) doi:
Wright N, Wise R, Hegarty T 1983. "Cefotetan elimination in patients with varying degrees of renal dysfunction." The Journal of antimicrobial chemotherapy 11 Suppl doi:

1982

Wise R, Dyas A, Hegarty A, Andrews J M 1982. "Pharmacokinetics and tissue penetration of azthreonam." Antimicrobial agents and chemotherapy 22 (6) doi:
Gozzard D I, Geddes A M, Farrell I D, Eykyn S J, Phillips I, et al. 1982. "Ceftazidime--a new extended-spectrum cephalosporin." Lancet 1 (8282) doi:
Brown R M, Wise R, Andrews J M, Hancox J 1982. "Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration." Antimicrobial agents and chemotherapy 21 (4) doi:
Wise R, Andrews J M, Hancox J 1982. "In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compounds." Antimicrobial agents and chemotherapy 21 (3) doi:
Wise R, Wright N, Wills P J 1982. "Activity, stability, and pharmacology of the epimers of moxalactam." Reviews of infectious diseases 4 Suppl doi:

1981

Lüthy R, Blaser J, Bonetti A, Simmen H, Wise R, Siegenthaler W 1981. "Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime." Antimicrobial agents and chemotherapy 20 (5) doi:
Armstrong G C, Wise R, Brown R M, Hancox J 1981. "Comparison of ceftazidime and cefamandole pharmacokinetics and blister fluid concentrations." Antimicrobial agents and chemotherapy 20 (3) doi:
Wise R, Wills P J, Bedford K A 1981. "Epimers of moxalactam: in vitro comparison of activity and stability." Antimicrobial agents and chemotherapy 20 (1) doi:
Wise R, Wright N, Wills P J 1981. "Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic disease." Antimicrobial agents and chemotherapy 19 (4) doi:
Wise R, Andrews J M, Bedford K A 1981. "Cefoperazone and cefotiam--two new cephalosporins: an in-vitro comparison." The Journal of antimicrobial chemotherapy 7 (4) doi:

1980

Reeves D S, Holt A, Bywater M J, Wise R, Logan M N, et al. 1980. "Comparison of sensititre dried microtitration trays with a standard agar method for determination of minimum inhibitory concentrations of antimicrobial agents." Antimicrobial agents and chemotherapy 18 (6) doi:
Wise R, Baker S, Livingston R 1980. "Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels." Antimicrobial agents and chemotherapy 18 (3) doi:
Seddon M, Wise R, Gillett A P, Livingston R 1980. "Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin." Antimicrobial agents and chemotherapy 18 (2) doi:
Wise R, Gillett A P, Cadge B, Durham S R, Baker S 1980. "The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics." The Journal of infectious diseases 142 (1) doi:
Wise R, Andrews J M, Bedford K A 1980. "Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds." Antimicrobial agents and chemotherapy 17 (5) doi:
Wise R, Andrews J M, Bedford K A 1980. "UK31214, a new aminoglycoside and derivative of kanamycin B." Antimicrobial agents and chemotherapy 17 (3) doi:
Wise R, Wills P J, Andrews J M, Bedford K A 1980. "Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins." Antimicrobial agents and chemotherapy 17 (1) doi:

1979

Welling P G, Dean S, Selen A, Kendall M J, Wise R 1979. "Probenecid: an unexplained effect on cephalosporin pharmacology." British journal of clinical pharmacology 8 (5) doi:
Durham S R, Bignell A H, Wise R 1979. "Interference of cefoxitin in the creatinine estimation and its clinical relevance." Journal of clinical pathology 32 (11) doi:
Wise R, Andrews J M, Dean S, Welling P G, Kendall M J 1979. "A pharmacological and in vitro comparison of three oral cephalosporins." The Journal of antimicrobial chemotherapy 5 (5) doi:
Ellis C J, Geddes A M, Davey P G, Wise R, Andrews J M, Grimley R P 1979. "Mezlocillin and azlocillin: an evaluation of two new beta-lactam antibiotics." The Journal of antimicrobial chemotherapy 5 (5) doi:
Wise R, Andrews J M, Bedford K A 1979. "LY127935, a novel oxa-beta-lactam: an in vitro comparison with other beta-lactam antibiotics." Antimicrobial agents and chemotherapy 16 (3) doi:
Welling P G, Dean S, Selen A, Kendall M J, Wise R 1979. "The pharmacokinetics of the oral cephalosporins cefaclor, cephradine and cephalexin." International journal of clinical pharmacology and biopharmacy 17 (9) doi:
Ayliffe G A, Babb J R, Taylor L, Wise R 1979. "A unit for source and protective isolation in a general hospital." British medical journal 2 (6188) doi:
Wills P J, Wise R 1979. "Rapid, simple enzyme immunoassay for gentamicin." Antimicrobial agents and chemotherapy 16 (1) doi:
Wise R, Cadge B, Gillett A P, Bhamjee A, Livingston R, et al. 1979. "Pharmacokinetics of Bay k 4999, a new broad-spectrum penicillin." Antimicrobial agents and chemotherapy 15 (5) doi:
Gillett A P, Andrews J M, Wise R 1979. "Comparative in vitro microbiological activity and stability of cefaclor." Postgraduate medical journal 55 Suppl 4 doi:

1978

Wise R, Rollason T, Logan M, Andrews J M, Bedford K A 1978. "HR 756, a highly active cephalosporin: comparison with cefazolin and carbenicillin." Antimicrobial agents and chemotherapy 14 (6) doi:
Wise R, Andrews J M, Bedford K A 1978. "Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs." Antimicrobial agents and chemotherapy 14 (4) doi:
Wise R, Andrews J M 1978. "UK-18892, a new aminoglycoside: an in vitro study." Antimicrobial agents and chemotherapy 14 (2) doi:
Wise R, Gillett A P, Andrews J M, Bedford K A 1978. "Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins." Antimicrobial agents and chemotherapy 13 (4) doi:
Wise R, Andrews J M, Bedford K A 1978. "In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin." Antimicrobial agents and chemotherapy 13 (3) doi:

1977

Skinner A, Wise R 1977. "A comparison of three rapid methods for the detection of beta-lactamase activity in Haemophilus influenzae." Journal of clinical pathology 30 (11) doi:
Wise R, Pippard M, Mitchard M 1977. "The disposition of sodium fusidate in man." British journal of clinical pharmacology 4 (5) doi:
Mitchard M, Andrews J, Kendall M J, Wise R 1977. "Mecillinam serum levels following intravenous injection: a comparison with pivmecillinam." The Journal of antimicrobial chemotherapy 3 Suppl B doi:
Strachan C J, Black J, Powis S J, Waterworth T A, Wise R, et al. 1977. "Prophylactic use of cephazolin against wound sepsis after cholecystectomy." British medical journal 1 (6071) doi:
Geddes A M, Schnurr L P, Ball A P, McGhie D, Brookes G R, et al. 1977. "Cefoxitin: a hospital study." British medical journal 1 (6069) doi:
McLeish A R, Strachan C J, Powis S J, Wise R, Bevan P G 1977. "The influence of biliary disease on the excretion of cefazolin in human bile." Surgery 81 (4) doi:
Bint A J, George R H, Healing D E, Wise R, Davies M 1977. "An outbreak of infection caused by a gentamicin-resistant Staphylococcus aureus." Journal of clinical pathology 30 (2) doi:
Wise R, Andrews J M, Bedford K A 1977. "The activity of four antimicrobial agents. Including three nitroimidazole compounds, against Bacteroides sp." Chemotherapy 23 (1) doi:

1976

Andrews J, Bywater M J, Emmerson A M, Keane C, Reeves D S, Wise R 1976. "The prevalence of ampicillin, cephalosporin and sulphonamide resistance amongst urinary tract pathogens." Scottish medical journal 20 (5) doi:
Gillett A P, Falk R H, Andrews J, Wise R, Melikian V 1976. "Rapid intravenous injection of tobramycin: suggested dosage schedule and concentrations in serum." The Journal of infectious diseases 134 Suppl doi:
Wise R 1976. "The 'septic spleen'--a critical evaluation." Journal of clinical pathology 29 (3) doi:
Wise R, Reeves D S, Symonds J M, Wilkinson P J 1976. "A clinical investigation of pivmecillinam. A novel beta-lactam antibiotic in the treatment of urinary tract infections." Chemotherapy 22 (5) doi:

1975

Wilkinson P J, Reeves D S, Wise R, Allen J T 1975. "Volunteer and clinical studies with carfecillin: a new orally administered ester of carbenicillin." British medical journal 2 (5965) doi:

1974

Wise R, Reeves D S, Parker A S 1974. "Administration of ticarcillin, a new antipseudomonal antibiotic, in patients undergoing dialysis." Antimicrobial agents and chemotherapy 5 (2) doi: